COVID-19 lessons for how pharma should support patient advocacy

Written By Neil McGregor-Paterson

Our Director of Connections and Collaborations Neil McGregor-Paterson has had a great article published in pharmaphorum COVID-19 lessons for how pharma should support patient advocacy.

This article unpicks the implications of the impact of COVID-19 on pharma's patient advocacy planning. It does this by considering real-time topics such as sustainability, health inequalities, the critical role of people and communities, creating health alongside prevention and treatment, and digital as a connector and enabler.

Click through and have a read!

https://pharmaphorum.com/views-analysis-patients/covid-19-lessons-for-how-pharma-should-support-patient-advocacy/

Neil McGregor-Paterson

Director of Connections and Collaboration at Trio Health

Neil has over 30 years’ experience in delivering connected programmes that draw on his extensive contacts and experience of working with the provider, policy maker, payer, advocacy, media and community health and care sectors. Neil also holds the position of Communications Director for New NHS Alliance, a national cross sector movement addressing health inequalities through Health Creation.

Previous

Trio Connect Newsletter Archive